The size of the Spinal Cord Stimulation Market in the Asia Pacific was worth USD 199.3 million in 2019 and estimated to reach USD 322.14 million by the end of 2024, with a growing potential of 10.08%. Asia-Pacific region is accounted to have the highest CAGR over the forecast period owing to increasing prevalence in pain.
Spinal cord stimulation, a treatment for pain that uses a mild current to block nerve impulses in the spine. The mild current is produced by a small device known as spinal cord stimulator which is implanted neat the spine. The pain is reduced because the electrical current interrupts the pain signals from reaching the brain. Cervical and lumbar radiculitis failed back surgery syndrome, complex regional pain syndrome is also helped by the therapy. Due to the increasing number of applications in various pain relief conditions, the demand for the SCS has been growing from years.
Some of the key factors that are driving the growth of the Asia-Pacific spinal cord stimulation market are rising adult population, rising demand for minimally invasive surgeries, the innovation of new technologies & therapies, increasing cases of obesity, and increasing aging demographics.
High costs related to therapy, stringent regulatory approvals, and major reliance on traditional SCS therapy are the restraints that are hindering the growth of the market.
This research report is segmented & sub-segmented into the following categories:
Notable companies leading the APAC Spinal Cord Stimulation market are Boston, Medtronic, Nevro, St. Jude Medical, Greatbatch and Stimwave.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Application
5.1.1 Introduction
5.1.2 Degenerative Disk Disease (DDD)
5.1.3 Failed Back Syndrome (FBS)
5.1.4 Unsuccessful Disk Surgery
5.1.5 Complex Regional Pain Syndrome (CRPS)
5.1.6 Multiple Back Operations
5.1.7 lumbar adhesive Arachnoiditis
5.1.8 Y-o-Y Growth Analysis, By Application
5.1.9 Market Attractiveness Analysis, By Application
5.1.10 Market Share Analysis, By Application
5.2 Product Type
5.2.1 Introduction
5.2.2 Non-Rechargeable
5.2.3 Rechargeable
5.2.4 Y-o-Y Growth Analysis, By Product Type
5.2.5 Market Attractiveness Analysis, By Product Type
5.2.6 Market Share Analysis, By Product Type
5.3 End-users
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Ambulatory Surgery Centers (ASC’s)
5.3.4 Clinics
5.3.5 Y-o-Y Growth Analysis, By End users
5.3.6 Market Attractiveness Analysis, By End users
5.3.7 Market Share Analysis, By End users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Application
6.1.3.3 By Product Type
6.1.3.4 End users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Application
6.1.4.3 By Product Type
6.1.4.4 By End users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Application
6.1.5.3 By Product Type
6.1.5.4 By End users
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Boston
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Medtronic
8.3 Nevro
8.4 St. Jude Medical
8.5 Greatbatch
8.6 Stimwave
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
